The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The fresh capital will propel Cordance into its first-in-human clinical trial
Renalyx will continue operating as an independent unit within the group
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Jaypirca is making waves in the fight against B-cell malignancies
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Subscribe To Our Newsletter & Stay Updated
